Switch to:
PDL BioPharma Inc (NAS:PDLI)
EV/EBIT
1.90 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its Earnings Before Interest and Taxes (EBIT). As of today, PDL BioPharma Inc's enterprise value is $1,059.9 Mil. PDL BioPharma Inc's earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2015 was $556.5 Mil. Therefore, PDL BioPharma Inc's EV/EBIT ratio for today is 1.90.

PDLI' s 10-Year EV/EBIT Range
Min: -54.9   Max: 508
Current: 1.88

-54.9
508

During the past 13 years, the highest EV/EBIT Ratio of PDL BioPharma Inc was 508.00. The lowest was -54.90. And the median was 4.00.

PDLI's EV/EBITis ranked higher than
91% of the 224 Companies
in the Global Biotechnology industry.

( Industry Median: 32.56 vs. PDLI: 1.88 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). PDL BioPharma Inc's enterprise value for the quarter that ended in Mar. 2015 was $1,263.5 Mil. PDL BioPharma Inc's earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2015 was $556.5 Mil. PDL BioPharma Inc's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2015 was 44.04%.


Definition

PDL BioPharma Inc's EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Earnings Before Interest and Taxes (EBIT) (TTM)
=1059.864/556.48
=1.90

PDL BioPharma Inc's current Enterprise Value is $1,059.9 Mil.
PDL BioPharma Inc's Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2015 was 155.914 (Jun. 2014 ) + 158.983 (Sep. 2014 ) + 99.457 (Dec. 2014 ) + 142.126 (Mar. 2015 ) = $556.5 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

PDL BioPharma Inc's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2015 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Mar. 2015 )=EBIT (TTM)/Enterprise Value (Q: Mar. 2015 )
=556.48/1263.47355
=44.04 %

PDL BioPharma Inc's Enterprise Value for the quarter that ended in Mar. 2015 was $1,263.5 Mil.
PDL BioPharma Inc's Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2015 was 155.914 (Jun. 2014 ) + 158.983 (Sep. 2014 ) + 99.457 (Dec. 2014 ) + 142.126 (Mar. 2015 ) = $556.5 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Earnings Yield (Joel Greenblatt), Earnings Before Interest and Taxes (EBIT)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

PDL BioPharma Inc Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebit -64.0810.767.204.254.155.873.103.223.462.58

PDL BioPharma Inc Quarterly Data

Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15
ev2ebit 3.223.062.882.733.463.273.852.582.582.27
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK